Kailera
Clinical trials sponsored by Kailera, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New weekly shot could help people with obesity shed pounds without diabetes Results expected May 2027 (estimated)
- New daily pill aims to shed pounds in obesity trial Results expected Jul 2027 (estimated)
-
New daily pill aims to shed pounds in obesity trial
Disease control OngoingThis study tests an experimental oral medication, KAI-7535, taken once daily to help people with obesity or overweight lose weight. About 320 adults with at least one weight-related condition (like high blood pressure or sleep apnea) will receive either the drug or a placebo for …
Phase 2 • Sponsor: Kailera • Aim: Disease control
Last updated Sep 10, 2026 03:00 UTC
-
New weekly shot could help people with obesity shed pounds without diabetes
Disease control OngoingThis study tests a new medicine called KAI-9531 (ribupatide) given as a weekly shot to help people with obesity lose weight. It includes 250 adults who have a BMI of 35 or higher and have tried to lose weight before without success. Participants will receive either the drug or a …
Phase 2 • Sponsor: Kailera • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC